Sir,

Thank you so much for your interest in our article and the important points that you have raised. We do agree that the total Vitamin B12 is a relatively late marker of B12 deficiency and alterations of holotranscobalamin and methylmalonic acid are much earlier to occur. However, we have mentioned that our series was only with those patients who presented to us with florid clinical manifestations such as bi/pancytopenia and/or pigmentation. We did not aim to search for subclinical cases of Vitamin B12 deficiency in this study. Given the number of overt cases we got in such short span, it is very likely that there are many more subclinical cases of Vitamin B12 deficiency in the region and this need to be evaluated in subsequent studies because it is easily treatable.

Patients already on Vitamin B12 supplementation were excluded only to keep the study design simple. As we have mentioned in the article, large scale, population-based studies are needed to further validate our findings.
